231 related articles for article (PubMed ID: 8617880)
1. Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling.
Kroder G; Bossenmaier B; Kellerer M; Capp E; Stoyanov B; Mühlhöfer A; Berti L; Horikoshi H; Ullrich A; Häring H
J Clin Invest; 1996 Mar; 97(6):1471-7. PubMed ID: 8617880
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
[TBL] [Abstract][Full Text] [Related]
4. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
6. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
Ahmed Z; Pillay TS
Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
[TBL] [Abstract][Full Text] [Related]
7. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
[TBL] [Abstract][Full Text] [Related]
8. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts.
Ide R; Maegawa H; Kikkawa R; Shigeta Y; Kashiwagi A
Biochem Biophys Res Commun; 1994 May; 201(1):71-7. PubMed ID: 8198614
[TBL] [Abstract][Full Text] [Related]
9. Elevation of tumor necrosis factor-alpha induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles: evidence for related gene expression of inflammatory, insulin and lipoprotein signaling in enterocytes.
Qin B; Dawson H; Anderson RA
Exp Biol Med (Maywood); 2010 Feb; 235(2):199-205. PubMed ID: 20404035
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition of insulin receptor signaling.
Rosenzweig T; Braiman L; Bak A; Alt A; Kuroki T; Sampson SR
Diabetes; 2002 Jun; 51(6):1921-30. PubMed ID: 12031982
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
Mishra S; Mathur R; Hamburger AW
Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
[TBL] [Abstract][Full Text] [Related]
12. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha.
Cheung AT; Ree D; Kolls JK; Fuselier J; Coy DH; Bryer-Ash M
Endocrinology; 1998 Dec; 139(12):4928-35. PubMed ID: 9832430
[TBL] [Abstract][Full Text] [Related]
13. Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance.
Hansen LL; Ikeda Y; Olsen GS; Busch AK; Mosthaf L
J Biol Chem; 1999 Aug; 274(35):25078-84. PubMed ID: 10455187
[TBL] [Abstract][Full Text] [Related]
14. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi P; Xu M; Spiegelman BM
J Clin Invest; 1997 Oct; 100(7):1863-9. PubMed ID: 9312188
[TBL] [Abstract][Full Text] [Related]
16. The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin.
Berti L; Kellerer M; Bossenmaier B; Seffer E; Seipke G; Häring HU
Horm Metab Res; 1998 Mar; 30(3):123-9. PubMed ID: 9566852
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide attenuates tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes.
Jin L; Shi G; Ning G; Li X; Zhang Z
Mol Cell Endocrinol; 2011 Jan; 332(1-2):134-9. PubMed ID: 20943205
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil GS; Murray DL; Choy LN; Spiegelman BM
Proc Natl Acad Sci U S A; 1994 May; 91(11):4854-8. PubMed ID: 8197147
[TBL] [Abstract][Full Text] [Related]
20. Orally efficacious novel small molecule 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose selectively and potently stimulates insulin receptor and alleviates diabetes.
Cao Y; Li Y; Kim J; Ren Y; Himmeldirk K; Liu Y; Qian Y; Liu F; Chen X
J Mol Endocrinol; 2013; 51(1):15-26. PubMed ID: 23549408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
